China Pharma Holdings, Inc.
CPHI · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $756 | $0 | $0 | $0 |
| % Growth | 73,722,002.6% | -9.7% | 0.2% | – |
| Gross Profit | -$60 | -$0 | -$0 | -$0 |
| % Margin | -7.9% | -8.5% | -12% | -4.9% |
| EBITDA | $379 | -$0 | -$0 | -$0 |
| % Margin | 50.1% | -17.6% | -37.7% | -65.8% |
| Net Income | -$651 | -$0 | -$0 | -$0 |
| % Margin | -86.2% | -51.5% | -69.1% | -108% |
| EPS Diluted | -0.17 | -0.16 | -0.18 | -0.26 |
| % Growth | -6.3% | 11.1% | 30.8% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |